Cancer

Colonoscopies finding a high rate of early onset colorectal cancer, Providence study finds

Providence researchers head to Chicago for leading cancer conference

Researchers at Earle A. Chiles Research Institute, a division of Providence Cancer Institute of Oregon, are helping shape the future of cancer care at the 2026 ASCO Annual Meeting in Chicago.

Adoptive cell therapy: Phase III study open for people with advanced melanoma

Inside the IMA203 phase III trial enrolling patients at Providence Cancer Institute.

It started with one bandage, and a patient’s smile

How novelty bandages have become a beloved tradition at Providence Cancer Institute Newberg Clinic.

New guidelines for treating head and neck cancer could be a game changer

New ASCO guidelines are designed to make the full body of evidence accessible to clinicians across specialties, including those who may not work routinely with a head and neck surgeon.

New Providence study identifies provider-patient relationships as central to colorectal cancer screening disparities

A new Providence study identifies barriers to colorectal cancer screening among racially diverse communities and is helping to shape outreach efforts to improve screening rates.

Providence receives esteemed NIH grant for ‘paradigm shift’ in head and neck cancer treatments

Providence cancer researchers will use a $3.4-million federal grant to study why a new treatment regimen is showing better outcomes against tumors that have been difficult to treat in the past.

Pioneering immunotherapy clinical trial enrolling patients with advanced cancers

A new medication called M3T01, developed at Providence Cancer Institute, takes a different approach to immunotherapy.

VOICES of Black Women: A community study in cancer prevention and care

A new study focused on stories will change health outcomes for Black women.

Leading the way: Providence researchers at AACR Annual Meeting

The annual AACR meeting draws the most innovative cancer researchers seeking breakthroughs in treatments.

Treatment options, time, and hope for one family's "chief memory maker"

After Virginia Kuo was diagnosed with lung cancer, Providence Swedish experts were committed to helping this mom of three have the life she envisioned with her husband and family. Learn more

A quiet lifeline: Meet the volunteer at Jill Lematta Learning Center

Cancer resources and compassion are plentiful in a quiet space at Providence Cancer Institute Franz Clinic.

Colon Cancer Is Rising in Younger Adults—Why Early Detection Matters More Than Ever

Colon cancer is no longer a disease that patients can assume only affects older adults. Colon Cancer Is Rising in Younger Adults—& Early Detection Matters More Than Ever

Gene therapy shows promising results against multiple myeloma

This study is now enrolling patients at Providence Cancer Institute – the only site outside of Australia.

Q&A: Colon cancer in younger adults, when to screen, symptoms and prevention

Dr. Kelly Perlewitz answers timely questions about the rise of colon cancer cases in younger adults.

Celebrating oncology social workers: Compassion, expertise and impact

We celebrate the work of oncology social workers, whose work is essential, transformative and deeply human.

6 things everyone should know about oncology palliative care

Palliative care can help manage pain, fatigue, anxiety and so much more – at any stage of cancer treatment.

Prostate cancer screening: What men need to know

Prostate cancer screening saves lives. Learn when to start PSA testing, what results mean, and how men in North Puget Sound can make informed screening decisions.

Providence receives Pfizer-funded Conquer Cancer grant to use revolutionary AI tool to predict cancer mutations

Pfizer Global Medical Grants has awarded $250,000 for Providence to use Prov-GigaPath to predict cancer mutations among Oregon patients